SB
SBC.US SBC Medical Group Holdings Incorporated
- Market cap
- USD 628M
- P/E
- 12.2x
- P/B
- 2.21x
- ROE
- 16.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SBC.US undervalued?
Graham numberSBC.US trades 9.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SBC Medical Group Holdings Incorporated fundamental analysis
No fundamental analysis for SBC Medical Group Holdings Incorporated yet.
SBC Medical Group Holdings Incorporated stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design…
Full company profileSBC Medical Group Holdings Incorporated financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SBC Medical Group Holdings Incorporated annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 174M | 194M | 205M | 174M | 201M |
| Gross Profit | 115M | 137M | 156M | 127M | 144M |
| Operating Income | 20.1M | 70.7M | 70.3M | 67.5M | 84.1M |
| EBITDA | 29.6M | 85.9M | 77.3M | 84.9M | 86.6M |
| Net Income | 6.32M | 39.4M | 46.6M | 51.0M | 50.3M |
| EPS | 0.42 | 0.42 | 0.48 | 0.50 | 0.49 |
| Balance Sheet | |||||
| Total Assets | 225M | 259M | 266M | 380M | 425M |
| Total Liabilities | 118M | 115M | 71.1M | 117M | 121M |
| Shareholders' Equity | 105M | 142M | 195M | 248M | 303M |
| Cash & Short-term Investments | 53.6M | 103M | 125M | 164M | 203M |
| Total Debt | 16.1M | 22.9M | 12.2M | 51.6M | 44.0M |
| Cash Flow | |||||
| Operating Cash Flow | -47.4K | 50.6M | 20.6M | 24.7M | 67.0M |
| Capital Expenditure | 24.9M | 11.2M | 3.41M | 2.37M | 2.97M |
| Free Cash Flow | -25.0M | 39.4M | 17.2M | 22.3M | 64.0M |
| Ratios | |||||
| ROE | 6.0% | 27.7% | 23.9% | 20.5% | 16.6% |
| ROA | 2.8% | 15.2% | 17.5% | 13.4% | 11.8% |
| Net Profit Margin | 3.6% | 20.3% | 22.7% | 29.4% | 25.0% |
| Debt to Equity | 0.15x | 0.16x | 0.06x | 0.21x | 0.15x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
SBC Medical Group Holdings Incorporated dividends
SBC Medical Group Holdings Incorporated has not paid dividends in the last 4 fiscal years.
Who owns SBC Medical Group Holdings Incorporated
- Insiders 81.53%
- Institutions 5.37%
- Public & others 13.09%
- Shares outstanding 103M
- Free float 18.1M
Top funds holding SBC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 447K | 0.44% | 0.00% | Oct 2026 |
| Fidelity Small Cap Index | 214K | 0.21% | 0.00% | Aug 2026 |
| Avantis US Small Cap Value ETF | 177K | 0.17% | +9.21% | Oct 2026 |
| iShares Russell 2000 Value ETF | 173K | 0.17% | 0.00% | Oct 2026 |
| Hillsdale US Micro Cap Equity Z US$ | 125K | 0.12% | 0.00% | Sep 2026 |
| Vanguard Russell 2000 ETF | 111K | 0.11% | -0.45% | Sep 2026 |
| Fidelity Extended Market Index | 89.4K | 0.09% | +48.33% | Sep 2026 |
| iShares Micro-Cap ETF | 58.5K | 0.06% | 0.00% | Oct 2026 |
| Schwab Small Cap Index | 46.9K | 0.05% | 0.00% | Sep 2026 |
| U.S. Equity Small Cap Corporate Cl OF | 42.7K | 0.04% | 0.00% | Jun 2026 |
| Fidelity Nasdaq Composite Index | 42.6K | 0.04% | 0.00% | Aug 2026 |
| iShares Russell 2000 Small-Cap Idx Instl | 38.2K | 0.04% | 0.00% | Sep 2026 |
| U.S. Equity Small Cap Pool A | 35.1K | 0.03% | 0.00% | Jun 2026 |
| Marsot Inversions SICAV SA | 32.7K | 0.03% | 0.00% | Oct 2026 |
| Fidelity Small Cap Value Index | 28.5K | 0.03% | +3.08% | Aug 2026 |
| Nuveen Small Cap Blend Idx R6 | 25.4K | 0.02% | 0.00% | Sep 2026 |
| Gestión Boutique VIII River Global FI | 23.8K | 0.02% | 0.00% | Oct 2026 |
| Fidelity Total Market Index | 18.8K | 0.02% | 0.00% | Sep 2026 |
| Vanguard Russell 2000 Value ETF | 17.8K | 0.02% | -0.82% | Sep 2026 |
Top institutions holding SBC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Lumbard Investment Counseling LLC | 1.73M | 1.68% | +9,899.47% | Jun 2026 |
| BlackRock Inc | 924K | 0.90% | +120.19% | Jun 2026 |
| Geode Capital Management, LLC | 428K | 0.42% | +44.66% | Jun 2026 |
| Citadel Advisors Llc | 145K | 0.14% | 0.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 136K | 0.13% | -0.33% | Jun 2026 |
| Northern Trust Corp | 131K | 0.13% | +43.96% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 128K | 0.13% | +101.89% | Jun 2026 |
| Hillsdale Investment Management Inc. | 125K | 0.12% | 0.00% | Jun 2026 |
| Segall Bryant & Hamill | 81.3K | 0.08% | 0.00% | Jun 2026 |
| American Century Companies Inc | 72.4K | 0.07% | 0.00% | Sep 2026 |
| Vanguard Fiduciary Trust Co | 66.3K | 0.06% | +6.10% | Jun 2026 |
| SBI Securities Co Ltd | 49.4K | 0.05% | +9.67% | Jun 2026 |
| State Street Corp | 49.2K | 0.05% | +59.66% | Jun 2026 |
| Charles Schwab Investment Management Inc | 46.9K | 0.05% | +157.43% | Jun 2026 |
| Mariner Wealth Advisors LLC | 33.7K | 0.03% | +40.85% | Jun 2026 |
| Bank of New York Mellon Corp | 27.0K | 0.03% | +165.14% | Jun 2026 |
| Nuveen, LLC | 25.4K | 0.02% | +105.22% | Jun 2026 |
| AQR Capital Management LLC | 24.1K | 0.02% | +91.65% | Jun 2026 |
| TWO SIGMA SECURITIES, LLC | 21.5K | 0.02% | 0.00% | Jun 2026 |
| Deutsche Bank AG | 18.8K | 0.02% | 0.00% | Jun 2026 |
SBC Medical Group Holdings Incorporated company profile
- Company name
- SBC Medical Group Holdings Incorporated
- Ticker
- SBC.US
- Exchange
- USA Stocks
- Listed since
- Sep 18, 2024
- Sector
- Industrials
- Industry
- Health Care Providers & Services
- Employees
- 863
- Fiscal year end
- December
- Address
- 200 Spectrum Center Dr., Irvine, CA, United States, 92618
- Phone
- 949 593 0250
- Website
- sbc-holdings.com
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.
SBC Medical Group Holdings Incorporated management
10- Dr. Yoshiyuki AikawaChairman & CEO · born 1971
- Mr. Yuya YoshidaCOO, CFO & Director · born 1980
- Ms. Miki YamazakiChief Strategy Officer · born 1986
- Mr. Ryoji MurataPrincipal Accounting Officer · born 1972
- Mr. Shinya InoueChief Marketing Officer
- Mr. Kazuki IchimoriChief Corporate Development Officer
- Taiki SakaguchiCHRO, Chief Planning Officer & Corporate Secretary
- Mr. Hiroyuki MiyaCOO of SBC Medical Group Co., Ltd. (Japan)
- Ms. Akiko WakiyamaChief Public Relations Officer
- Mr. Hikaru FukuiHead of IR & CHRO of SBC Medical Group Co., Ltd. (Japan)